Eyetcch Pharmaceuticals, Inc., a company that develops treatments 1″01″ eye problems, went public in…


Eyetcch Pharmaceuticals, Inc., a audience that develops treatments 1"01" eye problems, went exoteric in January 2004. Assisted by the cannonade bank Merrill Lynch, Eyetech sold 6.5 pet portion-outs at $21 each. There by prominence a aggregate of $136.5 pet. At the end of the loftyest day of trading, the fund sold for $32.40 per portion-out, down partially from a lofty of $33.00. Based on the el1d~of-day aggregate, Eyetech portion-outs were ostensible underpriced by environing $11 each, signification that the audience missed out on  an added $67 pet. IPO Pricing, The Eyetech. IPO Pricing. In the prior two questions. how would it favor your thinking to distinguish that in attention to the 6.5 pet portion-outs offered in the IPO, Eyetech had an added 32 pet portion-outs uncollected? Of those 32 pet portion-outs. 10 pet portion-outs were owned by pharmaceutical hercules Pfizer, and 12 pet portion-outs were owned by the 13 directors and supporter officers.